Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.116.001631PMID 28790152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy

  2017cited by this paper
• LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort.

  2016cited by this paper
• Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy

  2015cited by this paper
• Cytoskeletal prestress regulates nuclear shape and stiffness in cardiac myocytes

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• Broken nuclei--lamins, nuclear mechanics, and disease.

  2014cited by this paper
• Lamin A/C mutations in dilated cardiomyopathy.

  2014cited by this paper
• The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing

  2014cited by this paper
• Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies

  2013cited by this paper
• Disease-associated mutations in the coil 2B domain of human lamin A/C affect structural properties that mediate dimerization and intermediate filament formation.

  2013cited by this paper
• Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.

  2013cited by this paper
• Targeted Next‐Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics

  2013cited by this paper
• Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience

  2013cited by this paper
• Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy.

  2012cited by this paper
• Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.

  2012cited by this paper
• SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.

  2011cited by this paper
• Morphological Analysis of 13 LMNA Variants Identified in a Cohort of 324 Unrelated Patients With Idiopathic or Familial Dilated Cardiomyopathy

  2010cited by this paper
• Ultrastructural pathology of the nuclear envelope in familial lamin A/C cardiomyopathy.

  2010cited by this paper
• Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption

  2010cited by this paper
• The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button

  2010cited by this paper
• The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy

  2009cited by this paper
• The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress

  2009cited by this paper
• A logic programming approach to pedigree analysis.

  2008cited by this paper
• Long-term outcome and risk stratification in dilated cardiolaminopathies.

  2008cited by this paper
• Coding Sequence Mutations Identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 Patients with Familial or Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

  2008cited by this paper
• Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.

  2007cited by this paper
• High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

  2007cited by this paper
• Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene.

  2007cited by this paper
• Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.

  2007cited by this paper
• Phenotypic clustering of lamin A/C mutations in neuromuscular patients

  2007cited by this paper
• Primary prevention of sudden death in patients with lamin A/C gene mutations.

  2006cited by this paper
• Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress

  2005cited by this paper
• Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.

  2004cited by this paper
• Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

  2004cited by this paper
• Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.

  2003cited by this paper
• Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

  2003cited by this paper
• Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects

  2003cited by this paper
• Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.

  2002cited by this paper
• Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene.

  2002cited by this paper
• Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

  1999cited by this paper

• Cardiovascular Prognostic Impact of Missense vs Non-Missense Lamin A/C Variants: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Autosomal-Recessive LMNA Dilated Cardiomyopathy

  2025cites this paper
• Clinical and metabolic consequences of a historic pathogenic lamin A/C founder variant

  2025cites this paper
• Lamin variants cause cardiac arrhythmogenicity in Drosophila

  2025cites this paper
• Cardiac fibroblasts counterbalance cardiomyocytes in LMNA cardiomyopathy pathogenesis

  2025cites this paper
• Domain-specific association of single-nucleotide variants in the LMNA gene with the phenotypic expression of dilated cardiomyopathy.

  2025cites this paper
• Global Proteomic Analysis Reveals Alterations in Differentially Expressed Proteins between Cardiopathic Lamin A/C Mutations.

  2024cites this paper
• Persistent hypertension induces atrial remodeling and atrial fibrillation through DNA damage and ATM/CHK2/p53 signaling pathway.

  2024cites this paper
• The next era of gene‐specific clinical care in patients with dilated cardiomyopathy

  2024cites this paper
• REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy

  2024cites this paper
• Three-dimensional co-culturing of stem cell-derived cardiomyocytes and cardiac fibroblasts reveals a role for both cell types in Marfan-related cardiomyopathy.

  2024cites this paper
• Caenorhabditis elegans models for striated muscle disorders caused by missense variants of human LMNA

  2023cites this paper
• MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

  2023cites this paper
• Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain

  2023cites this paper
• Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation.

  2023cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

  2022cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

  2022cites this paper
• Atrial fibrillation

  2022cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

  2022cites this paper
• Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action

  2022cites this paper
• Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target

  2021cites this paper
• Cardiac phenotype in familial partial lipodystrophy

  2021cites this paper
• A splicing LMNA mutation causing laminopathies accompanied by aortic valve malformation

  2021cites this paper
• Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics

  2021cites this paper
• Management of heart failure with concomitant complete atrioventricular block caused by a novel missense LMNA mutation.

  2021cites this paper
• Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants

  2021cites this paper
• Come Together: Protein Assemblies, Aggregates and the Sarcostat at the Heart of Cardiac Myocyte Homeostasis

  2020cites this paper
• Predictores de riesgo en una cohorte española con cardiolaminopatías. Registro REDLAMINA

  2020cites this paper
• Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry.

  2020cites this paper
• A very long-term observation of a family with dilated cardiomyopathy and overlapping phenotype from lamin A/C mutation

  2020cites this paper
• Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy

  2020cites this paper
• Deciduous Teeth as an Alternative DNA Source for Post-Mortem Genetic Testing.

  2020cites this paper
• Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta‐analysis and systematic review

  2020cites this paper
• DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?

  2020cites this paper
• LMNA-mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy

  2019cites this paper
• Cardiometabolic assessment of lamin A/C gene mutation carriers: A phenotype-genotype correlation.

  2019cites this paper
• Biomechanical analysis of the mechanical environment of the cell nucleus in serum starvation-induced vascular smooth muscle cell differentiation

  2019cites this paper
• Atrial fibrillation

  2019cites this paper
• Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy

  2018cites this paper
• The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope

  2018cites this paper
• Phenotyping cardiomyopathy in adult zebrafish.

  2018cites this paper
• Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases

  2018cites this paper
• Functional Microdomains in Heart’s Pacemaker: A Step Beyond Classical Electrophysiology and Remodeling

  2018cites this paper
• Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants

  2018cites this paper
• Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities

  2018cites this paper
• Lamin missense mutations—the spectrum of phenotype variability is increasing

  2018cites this paper
• Untying the knot: protein quality control in inherited cardiomyopathies

  2018cites this paper
• Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry.

  2018cites this paper
• Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle

  2018cites this paper
• Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy

  2017cites this paper
• LMNA Mutations Associated With Mild and Late-Onset Phenotype: The Case of the Dutch Founder Mutation p.(Arg331Gln)

  2017cites this paper